CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.

Published in:

PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0262378

By:

• Bommi-Reddy, Archana;
• Park-Chouinard, Sungmi;
• Mayhew, David N.;
• Terzo, Esteban;
• Hingway, Aparna;
• Steinbaugh, Michael J.;
• Wilson, Jonathan E.;
• Sims III, Robert J.;
• Conery, Andrew R.

Publication type:

Article